Underfilling (revision 9)
Old revision·15:32, 4 Feb 2025·RetatrutideRuben
| Underfilling | |
|---|---|
Nominal fill is a label claim; delivered mass is a measurement. | |
| Failure | Delivered mass below nominal |
| Not detected by | Purity determination |
| Detected by | Gravimetric fill check, or content with fill mass |
| Topic infobox · conventions | |
Underfilling is the delivery of less material in a container than the quantity stated on its label. It is a distinct failure from impurity and is invisible to the determination most often supplied: area percent purity is normalised and does not change with the amount of material present.[1]
The quantity a purchaser cares about is the mass of peptide in the vial. That is the product of three things — the fill mass, the peptide content of the solid, and the purity — and a certificate reporting only the last of these constrains it hardly at all.[1]
Underfilling has been documented in independently examined research-chemical material. It is also the failure most easily checked without a laboratory, since it requires only a balance of adequate resolution and an empty vial of the same type for tare.[2]
Why purity does not detect it
[edit]Chromatographic purity is computed as the area of the main peak divided by the total integrated area, expressed as a percentage. Both terms scale with the amount injected, so the ratio is invariant to concentration over the linear range of the detector.[3]
A consequence is that a half-filled vial and a correctly filled vial of the same material give the same purity figure. The determination is answering a question about composition, and fill is a question about quantity.
The same reasoning applies to identity determinations. A mass spectrum confirms what a molecule is, not how much of it there is, unless the method is explicitly quantitative against a standard.
References
- ^ a b United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.
- ^ PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see Project:Sourcing guidelines).
- ^ United States Pharmacopeia, General Chapter <621>, Chromatography.